A citation-based method for searching scientific literature

Madhan Shanmugasundaram, J R Exequiel Pineda, Sangeetha Murugapandian. Curr Cardiol Rep 2021
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Posttranslational modifications of apolipoprotein A-II proteoforms in type 2 diabetes.
Ida Azizkhanian, Olgica Trenchevska, Yara Bashawri, Jiaqi Hu, Juraj Koska, Peter D Reaven, Randall W Nelson, Dobrin Nedelkov, Hussein N Yassine. J Clin Lipidol 2016
5
100



Effects of the SGLT2 inhibitor dapagliflozin on HDL cholesterol, particle size, and cholesterol efflux capacity in patients with type 2 diabetes: a randomized placebo-controlled trial.
Gian Paolo Fadini, Benedetta Maria Bonora, Giancarlo Zatti, Nicola Vitturi, Elisabetta Iori, Maria Cristina Marescotti, Mattia Albiero, Angelo Avogaro. Cardiovasc Diabetol 2017
43
100

Rationale and design of the expanded combination of evolocumab plus empagliflozin in diabetes: EXCEED-BHS3 trial.
Ikaro Breder, Jessica Cunha Breder, Isabella Bonilha, Daniel B Munhoz, Sheila T Kimura Medorima, Daniela C Oliveira, Helison R do Carmo, Camila Moreira, Anatol Kontush, Francesca Zimetti,[...]. Ther Adv Chronic Dis 2020
4
100

Remarkable quantitative and qualitative differences in HDL after niacin or fenofibrate therapy in type 2 diabetic patients.
Luís Masana, Anna Cabré, Mercedes Heras, Núria Amigó, Xavier Correig, Sergio Martínez-Hervás, José T Real, Juan F Ascaso, Helena Quesada, Josep Julve,[...]. Atherosclerosis 2015
14
100

Circulating levels of nitrated apolipoprotein A-I are increased in type 2 diabetic patients.
Ricardo Hermo, Cristina Mier, Mary Mazzotta, Masatomi Tsuji, Satoshi Kimura, Alejandro Gugliucci. Clin Chem Lab Med 2005
20
100

Mechanism of action of fibrates on lipid and lipoprotein metabolism.
B Staels, J Dallongeville, J Auwerx, K Schoonjans, E Leitersdorf, J C Fruchart. Circulation 1998
100


Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy.
William E Boden, Jeffrey L Probstfield, Todd Anderson, Bernard R Chaitman, Patrice Desvignes-Nickens, Kent Koprowicz, Ruth McBride, Koon Teo, William Weintraub. N Engl J Med 2011
100


High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes mellitus.
Brian G Drew, Stephen J Duffy, Melissa F Formosa, Alaina K Natoli, Darren C Henstridge, Sally A Penfold, Walter G Thomas, Nigora Mukhamedova, Barbora de Courten, Josephine M Forbes,[...]. Circulation 2009
261
100

Emerging therapies for raising high-density lipoprotein cholesterol (HDL-C) and augmenting HDL particle functionality.
Marcin Barylski, Peter P Toth, Dragana Nikolic, Maciej Banach, Manfredi Rizzo, Giuseppe Montalto. Best Pract Res Clin Endocrinol Metab 2014
56
100

Structure-function relationships of HDL in diabetes and coronary heart disease.
Mathias Cardner, Mustafa Yalcinkaya, Sandra Goetze, Edlira Luca, Miroslav Balaz, Monika Hunjadi, Johannes Hartung, Andrej Shemet, Nicolle Kränkel, Silvija Radosavljevic,[...]. JCI Insight 2020
22
100

Global and regional estimates and projections of diabetes-related health expenditure: Results from the International Diabetes Federation Diabetes Atlas, 9th edition.
Rhys Williams, Suvi Karuranga, Belma Malanda, Pouya Saeedi, Abdul Basit, Stéphane Besançon, Christian Bommer, Alireza Esteghamati, Katherine Ogurtsova, Ping Zhang,[...]. Diabetes Res Clin Pract 2020
115
100


HDL-Targeting Therapeutics: Past, Present and Future.
Emile Zakiev, Ma Feng, Vasily Sukhorukov, Anatol Kontush. Curr Pharm Des 2017
11
100

Genetic predisposition to dyslipidemia and type 2 diabetes risk in two prospective cohorts.
Qibin Qi, Liming Liang, Alessandro Doria, Frank B Hu, Lu Qi. Diabetes 2012
56
100

Nonenzymatic glycation of high-density lipoprotein impairs its anti-inflammatory effects in innate immunity.
Donghui Liu, Liang Ji, Dongmei Zhang, Xunliang Tong, Bing Pan, Pinli Liu, Youyi Zhang, Yining Huang, Jinzi Su, Belinda Willard,[...]. Diabetes Metab Res Rev 2012
28
100

The anti-inflammatory function of HDL is impaired in type 2 diabetes: role of hyperglycemia, paraoxonase-1 and low grade inflammation.
Sanam Ebtehaj, Eke G Gruppen, Mojtaba Parvizi, Uwe J F Tietge, Robin P F Dullaart. Cardiovasc Diabetol 2017
46
100

High-density lipoprotein of patients with type 2 diabetes mellitus elevates the capability of promoting migration and invasion of breast cancer cells.
Bing Pan, Hui Ren, Yijing Ma, Donghui Liu, Baoqi Yu, Liang Ji, Ling Pan, Jing Li, Liangui Yang, Xiaofeng Lv,[...]. Int J Cancer 2012
36
100

Glycation impairs high-density lipoprotein function.
C C Hedrick, S R Thorpe, M X Fu, C M Harper, J Yoo, S M Kim, H Wong, A L Peters. Diabetologia 2000
192
100

Glycation of HDL Polymerizes Apolipoprotein M and Attenuates Its Capacity to Bind to Sphingosine 1-Phosphate.
Tamaki Kobayashi, Makoto Kurano, Mai Nanya, Tomo Shimizu, Ryunosuke Ohkawa, Minoru Tozuka, Yutaka Yatomi. J Atheroscler Thromb 2021
5
100

Markers of Systemic Inflammation and Apo-AI Containing HDL Subpopulations in Women with and without Diabetes.
Giuseppina T Russo, Annalisa Giandalia, Elisabetta L Romeo, Angela Alibrandi, Katalin V Horvath, Bela F Asztalos, Domenico Cucinotta. Int J Endocrinol 2014
12
100

Effects of combination lipid therapy in type 2 diabetes mellitus.
Henry N Ginsberg, Marshall B Elam, Laura C Lovato, John R Crouse, Lawrence A Leiter, Peter Linz, William T Friedewald, John B Buse, Hertzel C Gerstein, Jeffrey Probstfield,[...]. N Engl J Med 2010
100

Sphingosine-1 phosphate prevents monocyte/endothelial interactions in type 1 diabetic NOD mice through activation of the S1P1 receptor.
Angela M Whetzel, David T Bolick, Suseela Srinivasan, Timothy L Macdonald, Margaret A Morris, Klaus Ley, Catherine C Hedrick. Circ Res 2006
92
100

Macrophage cholesterol efflux to plasma and HDL in subjects with low and high homocysteine levels: a FIELD substudy.
Marianna Maranghi, Anne Hiukka, Robert Badeau, Jouko Sundvall, Matti Jauhiainen, Marja-Riitta Taskinen. Atherosclerosis 2011
11
100

The Effects of Dapagliflozin on Systemic and Renal Vascular Function Display an Epigenetic Signature.
Anna Solini, Marta Seghieri, Livia Giannini, Edoardo Biancalana, Federico Parolini, Chiara Rossi, Angela Dardano, Stefano Taddei, Lorenzo Ghiadoni, Rosa Maria Bruno. J Clin Endocrinol Metab 2019
21
100

58
100

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.
D J Gordon, J L Probstfield, R J Garrison, J D Neaton, W P Castelli, J D Knoke, D R Jacobs, S Bangdiwala, H A Tyroler. Circulation 1989
100

The emerging role of HDL in glucose metabolism.
Brian G Drew, Kerry-Anne Rye, Stephen J Duffy, Philip Barter, Bronwyn A Kingwell. Nat Rev Endocrinol 2012
140
100

ApoCIII-enriched LDL in type 2 diabetes displays altered lipid composition, increased susceptibility for sphingomyelinase, and increased binding to biglycan.
Anne Hiukka, Marcus Ståhlman, Camilla Pettersson, Malin Levin, Martin Adiels, Susanne Teneberg, Eeva S Leinonen, Lillemor Mattsson Hultén, Olov Wiklund, Matej Oresic,[...]. Diabetes 2009
82
100

An update on sodium-glucose co-transporter-2 inhibitors for the treatment of diabetes mellitus.
Daniel S Hsia, Owen Grove, William T Cefalu. Curr Opin Endocrinol Diabetes Obes 2017
96
100

Plasma levels of Apolipoprotein A1 and Lecithin:Cholesterol Acyltransferase in type 2 diabetes mellitus: Correlations with haptoglobin phenotypes.
Samir Awadallah, Mohammed Madkour, Reem Al Hamidi, Esraa Abo Alwafa, Maram Hattab, Buhour Zakkour, Amna Al-Matroushi, Eslah Ahmed, Mariam Al-Kitbi. Diabetes Metab Syndr 2017
4
100


Effect of niacin on high-density lipoprotein apolipoprotein A-I kinetics in statin-treated patients with type 2 diabetes mellitus.
Jing Pang, Dick C Chan, Sandra J Hamilton, Vijay S Tenneti, Gerald F Watts, P Hugh R Barrett. Arterioscler Thromb Vasc Biol 2014
25
100

Niacin increases HDL biogenesis by enhancing DR4-dependent transcription of ABCA1 and lipidation of apolipoprotein A-I in HepG2 cells.
Lin-Hua Zhang, Vaijinath S Kamanna, Shobha H Ganji, Xi-Ming Xiong, Moti L Kashyap. J Lipid Res 2012
35
100

Effect of glucagon-like peptide-1 receptor agonists on lipid profiles among type 2 diabetes: a systematic review and network meta-analysis.
Feng Sun, Shanshan Wu, Jing Wang, Shuxia Guo, Sanbao Chai, Zhirong Yang, Lishi Li, Yuan Zhang, Linong Ji, Siyan Zhan. Clin Ther 2015
100
100

Altered distribution of plasma PAF-AH between HDLs and other lipoproteins in hyperlipidemia and diabetes mellitus.
Takeshi Kujiraoka, Tadao Iwasaki, Mitsuaki Ishihara, Mayumi Ito, Makoto Nagano, Akito Kawaguchi, Sadao Takahashi, Jun Ishi, Masahiro Tsuji, Tohru Egashira,[...]. J Lipid Res 2003
41
100

Importance of paraoxonase 1 (PON1) as an antioxidant and antiatherogenic enzyme in the cardiovascular complications of type 2 diabetes: Genotypic and phenotypic evaluation.
Yasaman Shokri, Atena Variji, Mani Nosrati, Abbas Khonakdar-Tarsi, Anvarsadat Kianmehr, Zahra Kashi, Adele Bahar, Abouzar Bagheri, Abdolkarim Mahrooz. Diabetes Res Clin Pract 2020
16
100


Effects on lipid profile of dipeptidyl peptidase 4 inhibitors, pioglitazone, acarbose, and sulfonylureas: meta-analysis of placebo-controlled trials.
Matteo Monami, Valentina Vitale, Maria Luisa Ambrosio, Nadia Bartoli, Giulia Toffanello, Benedetta Ragghianti, Francesca Monami, Niccolò Marchionni, Edoardo Mannucci. Adv Ther 2012
60
100

Niacin increases HDL by reducing hepatic expression and plasma levels of cholesteryl ester transfer protein in APOE*3Leiden.CETP mice.
José W A van der Hoorn, Willeke de Haan, Jimmy F P Berbée, Louis M Havekes, J Wouter Jukema, Patrick C N Rensen, Hans M G Princen. Arterioscler Thromb Vasc Biol 2008
134
100


Fibrates for primary prevention of cardiovascular disease events.
Tobias Jakob, Alain J Nordmann, Stefan Schandelmaier, Ignacio Ferreira-González, Matthias Briel. Cochrane Database Syst Rev 2016
63
100

Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease.
A Michael Lincoff, Stephen J Nicholls, Jeffrey S Riesmeyer, Philip J Barter, H Bryan Brewer, Keith A A Fox, C Michael Gibson, Christopher Granger, Venu Menon, Gilles Montalescot,[...]. N Engl J Med 2017
360
100

Diabetes Impairs Cellular Cholesterol Efflux From ABCA1 to Small HDL Particles.
Yi He, Graziella E Ronsein, Chongren Tang, Gail P Jarvik, W Sean Davidson, Vishal Kothari, Hyun D Song, Jere P Segrest, Karin E Bornfeldt, Jay W Heinecke. Circ Res 2020
8
100


Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds: a meta-analysis of randomized controlled trials.
Rakesh S Birjmohun, Barbara A Hutten, John J P Kastelein, Erik S G Stroes. J Am Coll Cardiol 2005
309
100

Epigenetic effects of metformin: From molecular mechanisms to clinical implications.
Stephanie Claire Bridgeman, Gaewyn Colleen Ellison, Phillip Edward Melton, Philip Newsholme, Cyril Desire Sylvain Mamotte. Diabetes Obes Metab 2018
66
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.